Effect of iTBS on Children With ADHD

Inclusion Criteria:

• Clinical diagnosis of ADHD in accordance with DSM-V;
• Age 6-12 years old, regardless of gender
• Right-handed
• Han nationality or born in the Han nationality Ghetto
• The course of the disease is greater than 6 months
• Webster children's intelligence ≥ 70
• The patient's guardian agrees and signs an informed consent form.

Exclusion Criteria:

• Concomitant mental disorders such as anxiety and depression;
• Widespread developmental disorders and other neurological developmental relateddisorders;
• Complication with other important organ diseases such as heart and lungs;
• Suffering from diseases such as epilepsy and tic disorder;
• Individuals who cannot tolerate rTMS treatment or cannot cooperate with treatment.
• Patients taking psychoactive drugs, antipsychotics, antidepressants, or moodstabilizers 3 months prior to enrollment or during rTMS treatment; In addition to theminimum effective therapeutic dose of Tomoxetine (1.2-1.4 mg • kg/day), there has beensystematic use of first-line ADHD drugs in clinical practice Webster's intelligence<70
• Implantation of metal and electronic components in the body (excluding the oralcavity), such as pacemakers;